Aurinia Pharmaceuticals Inc. (AUPH) Financials

AUPH Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 792.3 million 177.4 million
March 31, 2026 724.0 million 156.4 million
Dec. 31, 2025 751.6 million 170.3 million
Sept. 30, 2025 527.5 million 161.8 million

AUPH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 52.2 million 2.8 million
March 31, 2026 32.5 million -866000
Dec. 31, 2025 44.5 million 6.7 million
Sept. 30, 2025 44.4 million 5.9 million

AUPH Net Income

No data available :(

AUPH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 443.1 million - 60.4 million
March 31, 2026 378.8 million - 68.6 million
Dec. 31, 2025 398.0 million - 74.8 million
Sept. 30, 2025 351.8 million - 78.2 million

AUPH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 133.5 million
March 31, 2026 137.6 million
Dec. 31, 2025 138.7 million
Sept. 30, 2025 136.0 million

AUPH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 179 13.1 million 23.5 million -
March 31, 2026 39000 7.5 million 22.0 million 327000
Dec. 31, 2025 69764 10.9 million 29.3 million 785000
Sept. 30, 2025 65000 8.4 million 26.2 million 605000

AUPH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 83.2 million 6.6 million
March 31, 2026 77.7 million 6.5 million
Dec. 31, 2025 77.1 million 8.5 million
Sept. 30, 2025 73.5 million 8.5 million

AUPH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

AUPH

Price: $15.47

52 week price:
10.34
19.25

Earnings Per Share: 2.28 USD

P/E Ratio: 6.74

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Canada

Volume: 2.2 million

Ebitda: -13.4 million

Market Capitalization: 2.0 billion

Links: